Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Lantheus Holdings, Inc. - Common Stock (NQ:LNTH)

99.62 +0.09 (+0.10%)
Delayed Quote Updated: 1:53 PM EDT, Oct 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Lantheus Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
News headline image
Halper Sadeh LLC is Investigating Whether ITGR, FHB, INDV, LNTH are Obtaining Fair Deals for their Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Lantheus Announces CMS Grants Transitional Pass-Through Status for PYLARIFY® TruVu (piflufolastat F 18)
Designation, together with a permanent HCPCS code effective October 1, 2026, supports patient access and reimbursement for PYLARIFY TruVu, Lantheus' PSMA PET imaging agent 
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: SoundThinking, Inc. (Nasdaq – SSTI), Lantheus Holdings Inc. (Nasdaq – LNTH), MarketAxess Holdings Inc. (Nasdaq – MKTX), Sangoma Technologies Corporation (Nasdaq –
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Lantheus Announces First Patient Dosed in SPARROW Phase 2/3 Registrational Trial in Prostate Cancer
Study advances development of Lantheus' investigational GRPR-targeted PET imaging program for prostate cancer 
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
Halper Sadeh LLC is Investigating Whether HOWL, BZH, MKTX, LNTH are Obtaining Fair Deals for their Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Werewolf Therapeutics, Inc. (Nasdaq – HOWL), Beazer Homes USA, Inc. (NYSE – BZH), Lantheus Holdings Inc. (Nasdaq – LNTH), MarketAxess Holdings Inc. (Nasdaq – MKTX)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Lantheus Receives Final FDA Approval for BRAVNETSA™ (Lutetium Lu 177 Dotatate), the Only Radiopharmaceutical FDA has Determined to be Bioequivalent and Therapeutically Equivalent to LUTATHERA® for the Treatment of GEP-NETs
Approval of BRAVNETSA expands radioligand treatment options for adult patients with somatostatin receptor-positive (SSTR+) gastroenteropancreatic neuroendocrine tumors (GEP-NETs) 
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
Lantheus Holdings Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Lantheus Holdings, Inc. - LNTH
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
LNTH Stock Alert: Halper Sadeh LLC is Investigating Whether Lantheus Holdings, Inc. is Obtaining a Fair Price for its Shareholders
From Halper Sadeh LLC
Via Business Wire
News headline image
Lantheus Announces FDA Approval of TAUKLARIFY™ (Florquinitau F 18 Injection), an F18-Labeled Tau PET Imaging Agent for Alzheimer’s Disease
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
Halper Sadeh LLC is Investigating Whether LNTH, BOW, SAFT are Obtaining Fair Deals for their Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Bowman Consulting Group Ltd. (Nasdaq – BWMN), Bowhead Specialty Holdings Inc. (NYSE – BOW), Lantheus Holdings Inc. (Nasdaq – LNTH), Safety Insurance Group Inc.
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Lantheus Holdings Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Lantheus Holdings, Inc. - LNTH
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Lantheus Reports Second Quarter 2026 Financial Results
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
Halper Sadeh LLC is Investigating Whether MKTX, SMTI, LNTH are Obtaining Fair Deals for their Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Bowhead Specialty Holdings Inc. (NYSE – BOW), Lantheus Holdings Inc. (Nasdaq – LNTH), Safety Insurance Group Inc. (Nasdaq – SAFT), Neuphoria Therapeutics Inc. (Nasdaq
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Halper Sadeh LLC is Investigating Whether LNTH, ATKR, INDV are Obtaining Fair Deals for their Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
LNTH Stock Alert: Halper Sadeh LLC is Investigating Whether Lantheus Holdings, Inc. is Obtaining a Fair Price for its Shareholders
From Halper Sadeh LLC
Via Business Wire
News headline image
Curium Announces Definitive Agreement to Merge with Lantheus
From Curium
Via GlobeNewswire
News headline image
Lantheus to Host Second Quarter 2026 Earnings Conference Call and Webcast on August 6, 2026, at 8:00 a.m. Eastern Time
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
Lantheus Receives Complete Response Letter from FDA for LNTH-2501 (Ga 68 edotreotide)
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
Lantheus to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
Lantheus' LNTH-2513 (18F-GP1) PET/CT Awarded SNMMI’s Image of the Year
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
Lantheus to Present at the William Blair 46th Annual Growth Stock Conference
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
Lantheus Highlights New Radiodiagnostic Data at the 2026 SNMMI Annual Meeting
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
Lantheus Announces Presentation of Data at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
Lantheus Reports First Quarter 2026 Financial Results and Provides Business Update
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
Lantheus to Host First Quarter 2026 Earnings Conference Call and Webcast on May 7, 2026, at 8:00 a.m. Eastern Time
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
Lantheus Announces Three-Month Extension of PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs)
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
Lantheus Announces FDA Approval of PYLARIFY TruVu™ (piflufolastat F 18) Injection
From Lantheus Holdings, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.